FDA Will Reopen CBD Public Hearing Docket To Get More Data

By Beth Wang / March 6, 2020 at 4:17 PM
FDA plans to reopen the public docket for its May 2019 cannabidiol hearing so that stakeholders can share relevant data on CBD, agency chief Stephen Hahn said in a Thursday (March 5) press release, which provided an overview of FDA’s current work in the area. The press release provides much of the same information as FDA’s CBD regulatory report, which the agency recently sent to Congress. The push for additional public comment is part of FDA’s attempt to address data...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.